Earnings Feed
Start Free
ABIOMED INC·4

Jul 12, 4:58 PM ET

ABIOMED INC 4

4 · ABIOMED INC · Filed Jul 12, 2013

Insider Transaction Report

Form 4
Period: 2013-07-11
ABIOMED INCABMD
Bowen Robert
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Common Stock, $.01 par value

    2013-07-11$5.86/sh+1,499$8,784→ 68,428 total
  • Sale

    Common Stock, $.01 par value

    2013-07-11$23.50/sh−1,499$35,227→ 66,929 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2013-07-11−1,499→ 40,786 total
    Exercise: $5.86From: 2010-05-28Exp: 2019-05-28→ Common Stock (1,499 underlying)
Holdings

  • Stock Option (right to buy)

    Exercise: $22.44From: 2013-05-22Exp: 2022-05-22→ Common Stock (20,000 underlying)
    20,000

  • Stock Option (Right to Buy)

    Exercise: $23.15From: 2014-05-14Exp: 2024-05-14→ Common Stock (20,000 underlying)
    20,000

  • Stock Option (Right to Buy)

    Exercise: $15.92From: 2009-12-22Exp: 2018-12-22→ Common Stock (100,000 underlying)
    100,000

  • Stock Option (right to buy)

    Exercise: $5.86From: 2010-03-31Exp: 2019-05-28→ Common Stock (30,000 underlying)
    30,000

  • Stock Option (right to buy)

    Exercise: $10.03From: 2011-06-03Exp: 2020-06-03→ Common Stock (15,000 underlying)
    15,000
Footnotes (3)
  • [F1]Grant to reporting person of option to buy the number of shares of common stock set forth on Table II, Column 7, under the Abiomed, Inc. 2008 Stock Incentive Plan.
  • [F2]These options become exerciseable in annual 25% increments, commencing on the date set forth in Table II, Column 6.
  • [F3]Sale of common stock pursuant to reporting owner's 10b5-1 plan.

Documents

2 files